However, the question is whether the heterozygous GBA1 mutation in GBA1-PD, characterized by a moderate decrease in blood GCase activity and substrate accumulation, is sufficient to induce lysosomal dysfunction and thereby alter EV morphology. This evidence concerns the gene GBA1 and Parkinson disease.